Article
Generation and characterization of recombinant influenza A (H1N1) viruses harboring amantadine resistance mutations.
Antimicrobial agents and chemotherapy - 1 Feb 2005
Abed Yacine, Goyette Nathalie, Boivin Guy
Abstract excerpt
The emergence of resistance to amantadine in influenza A viruses has been shown to occur rapidly during treatment as a result of single-amino-acid substitutions at position 26, 27, 30, 31, or 34 within the transmembrane domain of the matrix-(M)-2 protein. In this study, reverse genetics was used to generate and characterize recombinant influenza A (H1N1) viruses harboring L26F, V27A, A30T, S31N, G34E, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
